Expert consensus on <italic>BRCA1/2</italic> gene testing and clinical application in Chinese breast cancer patients (2025 edition)
Breast cancer remains one of the frequently diagnosed malignant tumors among Chinese women, with hereditary cases accounting for 5%-10% of all diagnoses, where <italic>BRCA1/2</italic> gene mutations serve as the primary genetic predisposition factors. Although targeted therapies like poly (ADP-ribo...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Editorial Office of China Oncology
2025-07-01
|
| Saila: | Zhongguo aizheng zazhi |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2025.07.010 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|